The aberrant expression of CD180 in disease is also accompanied by functional differences, particularly in CLL where the receptor has apparently unique signaling properties which can powerfully regulate CLL cell behaviour and the action of the BCR. The gene discussed is CD180; the disease is B-cell chronic lymphocytic leukemia.